HIV-2 infection in 12 European residents: Virus characteristics and disease progression

AIDS

Volumn 10, Issue 14, 1996, Pages 1649-1655

  Van Der Ende, Marchina E ^a,b   Schutten, Martin ^b   Ly, Thoai Duong ^c   Gruters, Rob A ^b,d   Osterhaus, Albert D M E ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c Institute Alfred Fournier   (France)

^d UNIVERSITÉ DE LYON   (France)

Author keywords

Disease progression; HIV 2; Phenotype; Phylogeny; Zidovudine resistance

Indexed keywords

RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; NETHERLANDS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS GENE;

EID: 0029902224     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199612000-00009     Document Type: Article

References (23)

1. Barin F, M'Boup S, Denis F, et al.: Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet 1985, ii:1387-1389.
2. Clavel F, Guetard D, Brun-Vezinet F, et al.: Isolation of a new human retrovirus from West African patients with AIDS. Science 1986, 233:343-346.
3. Kanki PJ, De Cock KM: Epidemiology and natural history of HIV-2. AIDS 1994, 8 (suppl 1):S85-S93.
4. Whittle H, Morris J, Todd J, et al.: HIV-2-infected patients survive longer than HIV-1-infected patients. AIDS 1994, 8:1617-1620.
5. Marlink R, Kanki P, Thior I, et al.: Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994, 265:1587-1590.
6. Donnelly C, Leisenring W, Kanki P, Awerbuch T, Sandberg S: Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal. Bull Math Biol 1993, 55:731-743.
7. Andreasson PÅ, Dias F, Nauclér A, Andersson S, Biberfeld G: A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. AIDS 1993, 7:989-993.
8. Albert J, Nauclér A, Böttiger B, et al.: Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency. AIDS 1990, 4:291-295.
9. Schulz TF, Whitby D, Hoad JG, Corrah T, Whittle H, Weiss RA: Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia. J Virol 1990, 64:5177-5182.
10. Simon F, Matheron S, Tamalet C, et al.: Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993, 7:1411-1417.
11. Gao F, Yue L, Robertson DL, et al.: Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994, 68:7433-7447.
12. Clark SJ, Saag MS, Decker WD, et al.: High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection [see comments]. N Engl J Med 1991, 324:954-960.
13. Fiore JR, Bjorndal A, Peipke KA, et al.: The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology 1994, 204:297-303.
14. Gallo RC, Sarin PS, Gelmann EP, et al.: Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 1983, 220:865-867.
15. Schuitemaker H, Koot M, Kootstra NA, et al.: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 1992, 66:1354-1360.
16. Boom R, Sol CJ, Heijtink R, Wertheim-van Dillen PM, van der Noordaa J: Rapid purification of hepatitis B virus DNA from serum. J Clin Microbiol 1991, 29:1804-1811.
17. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41 (RR-17):1-19.
18. Meyers G, Korber B, Wain-Hobson S, Kuan-Teh J, Henderson LE, Pavlakis GN: Human Retroviruses and AIDS. Los Alomos: Los Alomos National Laboratories; 1994.
19. Larder BA, Darby G, Richman DD: HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989, 243:1731-1734
20. Tersmette M, de Goede RE, Al BJ, et al.: Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 1988, 62:2026-2032.
21. Fenyo EM, Morfeldt-Manson L, Chiodi F, et al.: Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 1988, 62:4414-4419.
22. Cheng-Mayer C, Seto D, Tateno M, Levy JA: Biologic features of HIV-1 that correlate with virulence in the host. Science 1988, 240:80-82.
23. Sharp PM, Robertson DL, Gao F, Hahn BH: Origins and diversity of human immunodeficiency viruses. AIDS 1994, 8 (suppl 1):S27-S42.